C
Cartesian Therapeutics
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune diseases - Cartesian
About Cartesian Therapeutics
Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company focused on developing novel cell and gene immunotherapies. These therapies are designed to treat a range of conditions including cancer, autoimmune diseases, and respiratory diseases. Founded in 2016, the company operates in the biotechnology sector and serves patients who are in need of advanced therapeutic options. Cartesian Therapeutics combines discovery, cGMP manufacturing, and clinical operations under one roof, ensuring a streamlined process from research to patient care. The business model revolves around the development and clinical testing of its proprietary therapies, which are then licensed or sold to larger pharmaceutical companies. Revenue is generated through these partnerships, as well as through grants and research funding. The company is currently engaged in multiple active clinical trials aimed at validating the efficacy and safety of its treatments.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Ballenger Creek, United States
- Listing
- IPO 2023
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Heart, Lung, and Blood Institute
Series A1 investor entered at this stage
- SCSchooner Capital
Series B and later5 investors entered at this stage
Timothy A. Springer
HBM Healthcare Investments
Invus
Surveyor Capital
K2 HealthVentures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
43 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cartesian Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cartesian Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.